Has Susan Xie, MD received payments from drug or device companies?

Yes. Drug and device makers reported $6,891 in general payments to Susan Xie, MD across 18 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Susan Xie, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Susan Xie, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Susan Xie, MD

Allergy & Immunology · Seattle, WANPI 1134651383

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $5,435 of the $6,891 with a category attached, or 78.9%. 8 manufacturers reported payments, led by Genentech USA, Inc. at 60.0% of the total.

$6,891in general payments, 2019–2025

Across 18 payments — averaging $382.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Genentech USA, Inc.$4K
Sanofi US Services Inc.$2K
Sanofi$187
Genentech, Inc.$155
AstraZeneca$139
Alk-abello, Inc$107
plus $56 from 2 others

What the payments were for

Consulting fees$5,43579%
Travel & lodging$4066%
Food & beverage$1,05115%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Genentech USA, Inc.	7	$4,135
Sanofi US Services Inc.	2	$2,113
Sanofi	2	$187
Genentech, Inc.	2	$155
AstraZeneca	2	$139
Alk-abello, Inc	1	$107
Novartis	1	$29
Ferring Pharmaceuticals Inc.	1	$26

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

XOLAIR$3,973
AYVAKIT$2,113

How this compares

$6,891 in reported general payments places this provider in the 75th percentile of 81 allergy & immunology providers in Washington.

See all allergy & immunology providers in Washington →

Medicare billing

Part B allowed, 2024

$12,485

Medicare patients

Services billed

213

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Dupixent PenDupilumab	24	$88,211
DuleraMometasone/Formoterol	19	$8,166
Fluticasone-SalmeterolFluticasone Propion/Salmeterol	19	$2,645
Budesonide	13	$2,200
Ipratropium Bromide	40	$1,009
Azelastine Hcl	16	$511

Paid to pharmacies, not to this prescriber.

Other allergy & immunology in Seattle

Frank VirantSeattle$107K
Leonard AltmanSeattle$81K
Daniel PetroniSeattle$68K
Rahool DaveSeattle$42K
Matthew AltmanSeattle$37K
Gabriel MendozaSeattle$16K
Kelly ColasSeattle$14K
Jing Yi SunSeattle$11K
Paul WilliamsSeattle$7K
Matthew PerezSeattle$6K

See the full list for Washington →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →